FGF23 and osteoarthritis: Thus starting treatment with burosumab only in adulthood will presumably not halt or reverse already developed osteoarthritis; but it may limit consequences of FGF23 excess on cartilage and prevent joint degeneration in case treatment is started before osteoarthritis is at an advanced stage.